$9.12
-0.31-3.29%
At close: Dec 15, 4:00 PM EST
$9.12
N/A
After Hours: 4:01 PM EST
Comments
Loading...
Design Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:DSGN | Benzinga
Design Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 9
EPS Estimate
$-0.330
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Design Therapeutics using advanced sorting and filters.
Design Therapeutics (DSGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $-0.30 | $-0.34 | 11.8 % |
| Q2 | 2025-08-07 | $-0.34 | $-0.33 | -3.03 % |
| Q1 | 2025-05-07 | $-0.31 | $-0.28 | -10.7 % |
| Q4 | 2025-03-10 | $-0.24 | $-0.27 | 11.1 % |
Design Therapeutics (DSGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?
Design Therapeutics (DSGN) is scheduled to report earnings on March 9, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
What were the latest earnings per share (EPS) for Design Therapeutics (NASDAQ:DSGN)?
The Actual EPS was $-0.30, which beat the estimate of $-0.34.
What were Design Therapeutics’s (NASDAQ:DSGN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
